FDA Expands Ecstasy Access to Veterans with PTSD

by | Feb 19, 2020

FDA Expands Ecstasy Access to Veterans with PTSD

by | Feb 19, 2020

In 2006, Johnathan Lubecky was deployed to Iraq. While fighting for his country, Johnathan faced constant enemy strikes, one of which resulted in a traumatic brain injury. Exposures to the horrors of war resulted in Johnathan developing post-traumatic stress disorder (PTSD).

Tragically, many soldiers share similar experiences. The U.S. Department of Veteran Affairs estimates between 11 and 20 percent of veterans serving in the War on Terror develop PTSD. Even for those with no military experience, PTSD is surprisingly common. An estimated 8 percent of the U.S. population (roughly equal in size to the population of Texas) will experience PTSD.

Treating PTSD is challenging, often requiring both medicinal treatment and considerable time spent in therapy. Unfortunately, some patients struggle to relive their traumatic experiences without suffering extreme emotional distress. In these cases, available treatments rarely help.

Many veterans fall into this category.

Read the rest at The Lighthouse.

Related Articles

Related

Pin It on Pinterest

Share This